Clinical trials
Completed Atherosclerosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
204 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 12 |
| 2010 | 10 |
| 2011 | 13 |
| 2012 | 9 |
| 2013 | 7 |
| 2014 | 16 |
| 2015 | 11 |
| 2016 | 22 |
| 2017 | 12 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 204 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 9 |
| Johns Hopkins University | 5 |
| University of Texas at Austin | 5 |
| Abbott Medical Devices | 4 |
| Emory University | 4 |
| Maastricht University Medical Center | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| InCor Heart Institute | 3 |
| Odense University Hospital | 3 |
| Sint Franciscus Gasthuis | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 204 |
| Cardiovascular Diseases | 35 |
| Coronary Artery Disease | 31 |
| Peripheral Arterial Disease | 20 |
| Inflammation | 15 |
| Obesity | 12 |
| Metabolic Syndrome | 11 |
| Diabetes Mellitus | 10 |
| Hypertension | 10 |
| Vascular Diseases | 10 |
Trials
Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.
104 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.